Cargando…

Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation

BACKGROUND: The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value‐baSed formulary Study (ACCESS) is a randomized controlled trial evaluating two interventions targeting barriers to care among those at high risk of cardiovascular disease: copayment elimination...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, David J. T., Saunders‐Smith, Terry, Manns, Braden J., Tonelli, Marcello, Ivers, Noah, Hemmelgarn, Brenda R., Tsuyuki, Ross T., Pannu, Raj, King‐Shier, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752191/
https://www.ncbi.nlm.nih.gov/pubmed/33047417
http://dx.doi.org/10.1111/hex.13133
_version_ 1783625806907441152
author Campbell, David J. T.
Saunders‐Smith, Terry
Manns, Braden J.
Tonelli, Marcello
Ivers, Noah
Hemmelgarn, Brenda R.
Tsuyuki, Ross T.
Pannu, Raj
King‐Shier, Kathryn
author_facet Campbell, David J. T.
Saunders‐Smith, Terry
Manns, Braden J.
Tonelli, Marcello
Ivers, Noah
Hemmelgarn, Brenda R.
Tsuyuki, Ross T.
Pannu, Raj
King‐Shier, Kathryn
author_sort Campbell, David J. T.
collection PubMed
description BACKGROUND: The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value‐baSed formulary Study (ACCESS) is a randomized controlled trial evaluating two interventions targeting barriers to care among those at high risk of cardiovascular disease: copayment elimination for cardioprotective medications, and a tailored self‐management support programme. We designed a process evaluation to better understand participant perspectives on the interventions. DESIGN: We used a qualitative descriptive study design, collecting patient and pharmacist feedback via individual semi‐structured telephone interviews and in‐person focus groups. Data were analysed inductively using thematic analysis. RESULTS: Fifty‐three patients (39 interviews and 14 in two focus groups) and 20 pharmacists participated. Copayment elimination provided quality of life benefits: minimizing the need to 'cut‐back', allowing 'peace of mind' and providing emotional support. Health‐related benefits included: improving adherence to covered medications, and helping to afford non‐covered goods. The only criticism was that not all medications and testing supplies were covered. Patients reported that the educational materials provided helpful information, acted as a reminder, improved confidence, improved adherence to medication, and helped initiate conversations with providers about indicated medication. Some participants felt that the educational materials were repetitive, overly medication‐focused and not tailored enough. Pharmacists felt that their patients benefitted from both interventions, which improved patient adherence and communication with their patients. CONCLUSION: The success of interventions intended to change behaviour is largely dependent upon participant's feelings that the intervention is helpful. This process evaluation provided insights into participants' perceptions on these interventions. Reception of both was largely positive with a few criticisms noted.
format Online
Article
Text
id pubmed-7752191
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77521912020-12-23 Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation Campbell, David J. T. Saunders‐Smith, Terry Manns, Braden J. Tonelli, Marcello Ivers, Noah Hemmelgarn, Brenda R. Tsuyuki, Ross T. Pannu, Raj King‐Shier, Kathryn Health Expect Original Research Papers BACKGROUND: The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value‐baSed formulary Study (ACCESS) is a randomized controlled trial evaluating two interventions targeting barriers to care among those at high risk of cardiovascular disease: copayment elimination for cardioprotective medications, and a tailored self‐management support programme. We designed a process evaluation to better understand participant perspectives on the interventions. DESIGN: We used a qualitative descriptive study design, collecting patient and pharmacist feedback via individual semi‐structured telephone interviews and in‐person focus groups. Data were analysed inductively using thematic analysis. RESULTS: Fifty‐three patients (39 interviews and 14 in two focus groups) and 20 pharmacists participated. Copayment elimination provided quality of life benefits: minimizing the need to 'cut‐back', allowing 'peace of mind' and providing emotional support. Health‐related benefits included: improving adherence to covered medications, and helping to afford non‐covered goods. The only criticism was that not all medications and testing supplies were covered. Patients reported that the educational materials provided helpful information, acted as a reminder, improved confidence, improved adherence to medication, and helped initiate conversations with providers about indicated medication. Some participants felt that the educational materials were repetitive, overly medication‐focused and not tailored enough. Pharmacists felt that their patients benefitted from both interventions, which improved patient adherence and communication with their patients. CONCLUSION: The success of interventions intended to change behaviour is largely dependent upon participant's feelings that the intervention is helpful. This process evaluation provided insights into participants' perceptions on these interventions. Reception of both was largely positive with a few criticisms noted. John Wiley and Sons Inc. 2020-10-13 2020-12 /pmc/articles/PMC7752191/ /pubmed/33047417 http://dx.doi.org/10.1111/hex.13133 Text en © 2020 The Authors. Health Expectations published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Papers
Campbell, David J. T.
Saunders‐Smith, Terry
Manns, Braden J.
Tonelli, Marcello
Ivers, Noah
Hemmelgarn, Brenda R.
Tsuyuki, Ross T.
Pannu, Raj
King‐Shier, Kathryn
Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title_full Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title_fullStr Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title_full_unstemmed Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title_short Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation
title_sort exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: a qualitative descriptive process evaluation
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752191/
https://www.ncbi.nlm.nih.gov/pubmed/33047417
http://dx.doi.org/10.1111/hex.13133
work_keys_str_mv AT campbelldavidjt exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT saunderssmithterry exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT mannsbradenj exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT tonellimarcello exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT iversnoah exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT hemmelgarnbrendar exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT tsuyukirosst exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT pannuraj exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation
AT kingshierkathryn exploringpatientandpharmacistperspectivesoncomplexinterventionsforcardiovascularpreventionaqualitativedescriptiveprocessevaluation